Please login to the form below

Not currently logged in
Email:
Password:

Jutta Heim joins Nuevolution

Takes role as director and scientific advisor at Danish discovery company

Nuevolution Jutta HeimNuevolution has appointed Prof Dr Jutta Heim as director and senior scientific advisor to its board of directors.

She brings to the Copenhagen-based small molecule lead discovery company more than 20 years of experiences working for Ciba-Geigy/Novartis.   

She was involved in the development and launch of anti-thrombotic and fibrinolytic products and established Novartis' oncology molecular genetics department.  

Prof Heim served as Novartis' senior scientific expert in molecular biology, was a member of its research management board and finished her time with the company heading the Novartis Lead Discovery Center with worldwide responsibility.  

She has also served as CSO at Swiss biopharma company Basilea Pharmaceutica, which focuses on anti-infectives, inflammation and oncology.  

Most recently Prof Heim was chief technology officer and chief scientific officer at health, wellness and nutrition company Evolva, 2009 to 2013.  

Alex Gouliaev, Nuevolution CEO, said: “Jutta's significant expertise and input has already been well appreciated by management and our board. We are certain that her experience from the industry, broad insight into general drug discovery and, in particular, within oncology will add significant value to the company.”

28th August 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics